1997
DOI: 10.1016/s0041-1345(96)00477-0
|View full text |Cite
|
Sign up to set email alerts
|

Adenoviral transfection of canine islet xenografts with immunosuppressive cytokine genes abrogates primary nonfunction and prolongs graft survival

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

1997
1997
2002
2002

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(4 citation statements)
references
References 1 publication
0
4
0
Order By: Relevance
“…This may turn out to be the case for immunoregulatory cytokines whose genes are expressed at very high levels when under the control of a strong promoter like that of cytomegalovirus. 11,21,37 Indeed, even 5% of islet cells secreting a soluble protein such as IL-1Ra following lentiviral infection, may adequately suppress an autoimmune or allogeneic immune response.…”
Section: Discussionmentioning
confidence: 99%
“…This may turn out to be the case for immunoregulatory cytokines whose genes are expressed at very high levels when under the control of a strong promoter like that of cytomegalovirus. 11,21,37 Indeed, even 5% of islet cells secreting a soluble protein such as IL-1Ra following lentiviral infection, may adequately suppress an autoimmune or allogeneic immune response.…”
Section: Discussionmentioning
confidence: 99%
“…In the case of IDDM, genetic modification of islets preceding transplantation has been shown to prolong graft survival by site-specific delivery of immunosuppressive molecules (Hunger et al, 1997;Korbutt et al, 1995;Deng et al, 1997a;Gainer et al, 1997Gainer et al, , 1998. Although retroviral or adenoviral vectors can transfer genes into primary cells, both systems have limitations for long-term transfer of genes into /3-cells.…”
Section: Overview Summarymentioning
confidence: 99%
“…Cellular antigens can be modified to reduce recognition by the immune system (89). Immunomodulatory cytokines, such as interleukin (IL)-4, IL-10, IL-12, or TGF-0 (transforming growth factor-p), can be released locally to alter cellular responses (90). Co-stimulation pathways for T-cell activation can be blocked with CTLA4 or other proteins (91).…”
Section: Scientific Impediments Current State Of the Art For Islet Trmentioning
confidence: 99%